Evidence map›Paper›PMID 36669509›Full record

ArticleArchives of pathology & laboratory medicine2023

Graph Convolutional Neural Networks for Histologic Classification of Pancreatic Cancer.

Weiyi Wu, Xiaoying Liu, Robert B Hamilton, Arief A Suriawinata, Saeed Hassanpour

Abstract read
In one paragraph

Article in Archives of pathology & laboratory medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Spatial Omics Driven Crossmodal Pretraining Applied to Graph-based Deep Learning for Cancer Pathology Analysis.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2024
    Article
  6. Article
  7. Improving Representation Learning for Histopathologic Images with Cluster Constraints.Proceedings. IEEE International Conference on Computer Vision · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Weiyi WuFrom the Department of Biomedical Data Science (Wu, Hassanpour), Geisel School of Medicine, Hanover, New Hampshire.
Xiaoying LiuThe Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (Liu, Hamilton, Suriawinata).
Robert B HamiltonThe Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (Liu, Hamilton, Suriawinata).
Arief A SuriawinataThe Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (Liu, Hamilton, Suriawinata).
Saeed HassanpourFrom the Department of Biomedical Data Science (Wu, Hassanpour), Geisel School of Medicine, Hanover, New Hampshire.

Funding

Advancing Digital Pathology through Novel Machine Learning MethodologiesR01LM013833 · NLM · DARTMOUTH COLLEGE · PI Saeed Hassanpour · 2022 to 2026
$3.0M
Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer ManagementR01CA249758 · NCI · DARTMOUTH COLLEGE · PI HASSANPOUR, SAEED · 2019 to 2022
$1.5M
Improving Colorectal Cancer Screening and Risk Assessment through Deep Learning on Medical Images and RecordsR01LM012837 · NLM · DARTMOUTH COLLEGE · PI HASSANPOUR, SAEED · 2019 to 2022
$1.4M
NCI NIH HHS R01 CA249758NLM NIH HHS R01 LM012837NLM NIH HHS R01 LM013833
6 · The paper itself

Abstract

CONTEXT.—: Pancreatic ductal adenocarcinoma has some of the worst prognostic outcomes among various cancer types. Detection of histologic patterns of pancreatic tumors is essential to predict prognosis and decide the treatment for patients. This histologic classification can have a large degree of variability even among expert pathologists. OBJECTIVE.—: To detect aggressive adenocarcinoma and less aggressive pancreatic tumors from nonneoplasm cases using a graph convolutional network-based deep learning model. DESIGN.—: Our model uses a convolutional neural network to extract detailed information from every small region in a whole slide image. Then, we use a graph architecture to aggregate the extracted features from these regions and their positional information to capture the whole slide-level structure and make the final prediction. RESULTS.—: We evaluated our model on an independent test set and achieved an F1 score of 0.85 for detecting neoplastic cells and ductal adenocarcinoma, significantly outperforming other baseline methods. CONCLUSIONS.—: If validated in prospective studies, this approach has a great potential to assist pathologists in identifying adenocarcinoma and other types of pancreatic tumors in clinical settings.

Indexed as

AdenocarcinomaPancreatic NeoplasmsHumansNeural Networks, ComputerPrognosisProspective Studies

Identifiers

PMID36669509
PMCPMC10356903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.